Article Per Year (5 Year)
p-Index From 2019 - 2024
0.408
P-Index
This Author published in this journals
All Journal Ophthalmologica Indonesiana
Athira Presialia
Unknown Affiliation
Health Professions Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
From the Eye to the Heart: Association between Age-Related Macular Degeneration and Cardiovascular Disease (a Systematic Review): Oral Presentation - Observational Study - General practitioner Sausan; Athira Presialia; Rasyad Khalifah; Gitalisa Andayani Adriono
Majalah Oftalmologi Indonesia Vol 49 No S2 (2023): Supplement Edition
Publisher : The Indonesian Ophthalmologists Association (IOA, Perhimpunan Dokter Spesialis Mata Indonesia (Perdami))

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35749/ax8d9687

Abstract

Introduction & ObjectivesAge-related macular degeneration (AMD) is the third leading cause of global blindness, whilecardiovascular disease (CVD) is recognized as a major cause of morbidity and mortality. Both arecomplex diseases associated with aging. It has recently been argued that there is an associationbetween AMD and CVD. This study examined whether AMD increased the risk of CVD and/ or CVDmortality. MethodsA systematic review was conducted through three databases (Pubmed, Scopus, and Embase) forrelevant studies published between 2016-2023. We selected studies which focused on subjects withAMD, regardless of stages, and their risks for developing CVD and/or CVD mortality. ResultsTwo cohort studies and one case-control study are included, involving 93.388 patients aged >40years old. One cohort study found that subjects with choroidal neovascularization were associatedwith an increased rate of cardiovascular mortality (HR 3.16 95% CI 1.62-6.15). Another study alsofound that AMD was associated with a 1.58 fold increased risk of heart failure (adjusted OR, 1.56;95% CI, 1.16–1.87; P<0.001) after adjustment for confounders. Moreover, aside from the variableson which this systematic review focused on, the cohort studies also found AMD correlation withother diseases and causes of mortality. ConclusionIndividuals with AMD have higher risk for developing CVD. Thus, screening for AMD may bebeneficial in preventing CVD.
Virna Glaucoma Implant (VGI) as the Management of Secondary Glaucoma following TASS : A Case Report: Poster Presentation - Case Report - General practitioner Athira Presialia; Anissa Nindhyatriayu Witjaksono; Gisela Haza Anissa; Syska Widyawati
Majalah Oftalmologi Indonesia Vol 49 No S2 (2023): Supplement Edition
Publisher : The Indonesian Ophthalmologists Association (IOA, Perhimpunan Dokter Spesialis Mata Indonesia (Perdami))

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35749/4sepeq10

Abstract

Introduction : Secondary glaucoma may occur in severe TASS. The inflammatory cell and debris can clog trabecular meshwork causing IOP to rise. In this case, we describe the successful management of secondary glaucoma due to TASS using Virna Glaucoma Implant (VGI). Case Illustration : A 66-year-old woman presented with decreased vision in the left eye one week after anterior vitrectomy and anterior segment lavage due to TASS. She had a history of phacoemulsification and intraocular lens placement with complication of PCR. On ocular examination, the visual acuity was 1/60 in the left eye with intraocular pressure (IOP) 55 mmHg. After maximum glaucoma medication using timolol, latanoprost, brinzolamide eye-drops and oral acetazolamide IOP was 22mmHg. Glaucoma Drainage Device (GDD) surgery using VGI was performed. After 2.5 weeks, IOP in the left eye was reduced to 19 mmHg without anti-glaucoma medication and visual acuity has improved to 6/60, showing a favourable outcome. Discussion : TASS may cause significant damage to the trabecular meshwork, which leads to secondary glaucoma. Although medical therapy is often used to control elevated IOP, surgical therapy may be required to treat refractor IOP elevation. GDD surgery has been reported to have effective outcomein secondary glaucoma and pseudophakic eyes. Conclusion : Secondary glaucoma is considered as one of the characteristics in the late stages of TASS, and required prompt treatment. VGI implantation is a promising choice of treatment in managing secondary glaucoma following TASS when medication is not effective.
Co-Authors Anissa Nindhyatriayu Witjaksono Gisela Haza Anissa Gitalisa Andayani Adriono Rasyad Khalifah Sausan Syska Widyawati